Serina Therapeutics, Inc. ($SER)
Filing Information
| Accession Number | 0001301120-26-000004 |
|---|---|
| Form Type | 4 |
| Filing Date | Jan 14, 2026 |
| Document Date | Jan 13, 2026 |
| Document | View SEC Filing |
Transactions
6
Total Shares
19,500
Total Value
$16,643.36
Transactions
| Name | Title | Security | Derivative | Transaction Date | Type | Shares | Price | Total Cost | Shares After | Direct/Indirect | Nature of Ownership | Actions |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Chief Scientific Officer | Common Stock | โ | Jan 13, 2026 | Exercise/Conversion | 5,416 | $0.06 | $324.96 | 5,416 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 13, 2026 | Sale | 5,416 | $2.50 | $13,540.00 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 14, 2026 | Exercise/Conversion | 1,084 | $0.06 | $65.04 | 1,084 | Direct | โ | View Details | |
Chief Scientific Officer | Common Stock | โ | Jan 14, 2026 | Sale | 1,084 | $2.50 | $2,713.36 | 0 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jan 13, 2026 | Exercise/Conversion | 5,416 | $0.00 | $0.00 | 333,770 | Direct | โ | View Details | |
Chief Scientific Officer | Stock Option (right to buy) | Derivative | Jan 14, 2026 | Exercise/Conversion | 1,084 | $0.00 | $0.00 | 332,686 | Direct | โ | View Details |